Skip to main content

Decibel Therapeutics, Inc.

DBTXDelisted Sep 25, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001656536

Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Decibel Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of DBTX: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders4636−10
Shares19.6M18.9M−673.6K (−3.4%)
Value$168.1M$145.9M−$22.2M (−13.2%)

New holders (4)

Institutions that held Decibel Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to DBTX in Q3 2021
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP22,426$173.0K0.00%
Ergoteles LLC19,968$154.0K0.01%
State Street Corp15,700$121.0K0.00%
Evoke Wealth, LLC100$00.00%

Sold out (14)

Institutions that held Decibel Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of DBTX in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Janus Henderson Group PLC682,597$5.75M
Zimmer Partners, LP50,000$430.0K
Tibra Equities Europe Ltd43,400$373.0K
Two Sigma Investments, LP34,001$292.0K
Alberta Investment Management Corp30,000$258.0K
Alyeska Investment Group, L.P.27,047$233.0K
Renaissance Technologies LLC15,900$137.0K
Norges Bank15,000$129.0K
Jacobs Levy Equity Management, Inc13,594$117.0K
O'Shaughnessy Asset Management, LLC12,821$110.0K
Legal & General Group Plc1,742$15.0K
Advisory Services Network, LLC1,000$9.00K
UBS Group AG514$4.00K
New York State Common Retirement Fund52$0